TLPH

Talphera Inc

1.070

+0.020+1.90%

After Hours: 1.070 0.000 0.00%18:43 07/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.050/1.050

TODAY RANGE1.030-1.100

VOL427.10K

MARKET CAP55.53M

52 WEEK RANGE0.3800-1.570

AVG VOL (3M)184.39K

% TURNOVER0.82%

TURNOVER--

P/E (TTM)-3.5584

% RANGE6.19%

EPS(TTM)-0.3007

P/E(FORWARD)-4.2800

P/B2.898

BVPS0.3692

DIVIDEND--

P/S1,783.33

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP39.99M

SHARES OUTSTANDING51.90M

NEXT EARNINGS08/12-08/17

FREE FLOAT37.37M

LOT SIZE1

EX-DATE10/26/2022

News

Press Releases

Financial Reports

Profile

TipRanks·06/23 21:20
Talphera Shareholders Approve Directors and Governance Proposals
PUBT·06/23 20:28
Talphera shareholders approve amended 2020 equity incentive plan at annual meeting
TipRanks·06/06 09:01
Dollar Tree, Onto, Chipotle, Lululemon, Talphera Trending
Dow Jones·06/05 12:51
Talphera Price Target Announced at $3.00/Share by HC Wainwright & Co.
Dow Jones·06/05 12:51
Talphera Coverage Assumed by HC Wainwright & Co. at Buy
TipRanks·06/05 10:27
Talphera assumed with a Buy at H.C. Wainwright
TipRanks·05/20 00:27
Talphera Earnings Call Highlights NEPHRO Trial Momentum
NASDAQ·05/19 16:14
Talphera Reports Q1 Loss Of $2 Mln; Completes 50% Enrolment In Phase 3 Trial
TipRanks·05/15 00:29
Talphera Earnings Call Highlights Trial Momentum, Risks
PUBT·05/14 12:01
CorMedix Q1 net income rises to $38.6 million; revenue more than doubled to $127.4 million
TipRanks·05/14 11:42
Wall Street Analysts Are Bullish on Top Healthcare Picks
Seeking Alpha·05/13 23:21
Talphera targets Niyad PMA filing in 2026 and potential approval in 2027 as NEPHRO enrollment surpasses 50%
TipRanks·05/13 21:03
Talphera reports Q1 EPS (4c) vs. (10c) last year
Reuters·05/13 20:18
Talphera Q1 net loss narrows as costs rise on higher development spending
Seeking Alpha·05/13 20:09
Talphera GAAP EPS of -$0.04 beats by $0.04

Same Industry

Name/Symbol

Change%

Price

MCK

Biogen Inc

BIIB

+6.97%

216.03

Amgen Inc

AMGN

+0.44%

362.12

Shire

SHPG

0.00%

179.20

CELG-RT

Lilly Eli & Co

LLY

+7.13%

CELG

Therapeuticsmd Inc

TXMD

+1.43%

2.191

Johnson & Johnson

JNJ

+2.70%

260.83

ABBV

Zoetis Inc

ZTS

-1.90%

71.86

Gilead Sciences Inc

GILD

+0.01%

126.34

Novo-Nordisk A/S

NVO

-0.83%

47.94

BMY

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+2.45%

24.47

SNY

GCVRZ

Novartis

NVS

-1.65%

154.14

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.